串扰
化学
癌细胞
小分子
程序性细胞死亡
癌症研究
脂质过氧化
细胞生物学
GPX4
索拉非尼
肝癌
癌症
细胞凋亡
生物化学
生物
肝细胞癌
谷胱甘肽
氧化应激
遗传学
物理
光学
酶
谷胱甘肽过氧化物酶
作者
Linzhou Yin,Pengyu Liu,Yue Jin,Zunxi Ning,Yiren Yang,Huiyuan Gao
标识
DOI:10.1016/j.ejmech.2022.114861
摘要
Ferroptosis is a novel type of regulated cell death which is driven by iron-dependent lipid peroxidation and subsequent plasma membrane ruptures. Since ferroptosis was coined fairly in 2012, the research in the field of ferroptosis has grown at an exponential rate. Several small-molecule drugs have been shown to trigger ferroptosis and decrease tumor growth in the last decade. Sorafenib can induce ferroptosis in human hepatocellular carcinoma cell lines (Huh7, Hep3B and HepG2), and sulfasalazine as a ferroptosis inducer can inhibit the proliferation of a series of cancer cell lines (including HT-1080 fibrosarcoma cells, Calu-1 non-small cell lung cancer cells, etc.) by specifically inhibit cystine transport which mediated by system Xc-. The purpose of this review is discussing the current crosstalk between ferroptosis and tumor-related signaling pathways, as well as comprehensively summarizing the small-molecule compounds that may regulate cancer cells death by inducing ferroptosis which will shed new light on the development of ferroptosis-related anticancer drugs in the future.
科研通智能强力驱动
Strongly Powered by AbleSci AI